baber/WOPTO huggingface dataset:
Patent EP-3974802-A1 (EP)
Inventor: USPENSKIJ SERGEJ ALEKSEEVICH
IPC: B82Y5/00
Filed: 2020-04-15
Abstract: The group of inventions is related to the field of medical technologies, namely, to the creation of target agents for boron-neutron capture therapy of oncological diseases, and describes variants of a method for obtaining a composition containing elemental boron nanoparticles. According to the first variant, the method for preparing a composition for boron neutron capture therapy of malignant tumors containing boron nanoparticles less than 100 nm in size includes the following steps: the elemental boron powder is placed in water and treated for 0.5 to 800 minutes with ultrasound with the vibration intensity from 1, 0 to 1000.0 W / cm 3  and the output power of more than 100.0 W. According to the second variant, the method for preparing a composition for boron neutron capture therapy of malignant tumors containing boron nanoparticles less than 100 nm in size includes the following steps: an elemental boron powder is placed in water and treated for 30 to 300 minutes with ultrasound with a vibration intensity from 1.0 to 1000.0 W / cm 3  and an output power of more than 100.0 W, then the upper part of the composition is taken in a volume of less than 50.0 vol.% of the total composition volume and this part is treated with ultrasound with the vibration intensity from 1.0 to 1000.0 W / cm 3  and an output power of more than 100.0 W for 250-300 minutes. The technical result of the proposed group of inventions is obtaining compositions for boron-neutron capture therapy of malignant tumors with a high content of boron nanoparticles stable in time.
Patent EP-4073324-A1 (EP)
Inventor: RATHAMMER ANDRE
IPC: E03C1/322
Filed: 2020-12-07
Abstract: L'invention concerne un agencement pour l'installation et le montage d'un lavabo (1), une boîte de montage (4) qui peut être fixée à une paroi (2) ou à un cadre de montage (3) et qui fournit des connexions pour l'entrée et la sortie d'eau et fournit un dispositif de fixation pour fixer le lavabo (1), l'agencement comprenant des éléments de maintien et de guidage (5) pour absorber principalement des forces verticales et pour le guidage pendant l'opération de montage, et comporte des éléments de fixation (6) pour la fixation à la paroi (2) ou à un cadre de montage (3).
Patent EP-3983397-A1 (EP)
Inventor: ADAIR CHRISTOPHER
IPC: C07B35/08
Filed: 2020-06-11
Abstract: Disclosed is a method for converting a first cannabinoid into a second cannabinoid that is a regioisomer of the first cannabinoid. The method comprises contacting the first cannabinoid with a Lewis-acidic heterogeneous reagent under reaction conditions comprising: (i) a reaction temperature that is within a target reaction-temperature range for the Lewis-acidic heterogeneous reagent and the first cannabinoid; and (ii) a reaction time that is within a target reaction-time range for the Lewis-acidic heterogeneous reagent, the reaction temperature, and the first cannabinoid.
Patent EP-4073932-A1 (EP)
Inventor: HUMER GERHARD
IPC: G06F7/58
Filed: 2020-12-09
Abstract: The invention relates to a method for generating random numbers, wherein a) a source (1) emits energy, in particular in the form of pulses, with a specified distribution at non-predictable points in time, b) a detector (3) which is connected downstream of the source (1) detects the energy emitted by the source (1), in particular in the form of pulses, c) optionally energy emitted by the source (1) is suppressed or attenuated by an attenuator (2) located between the source (1) and the detector (3), and d) the duration between a specified starting time (t0) and the point in time at which a pulse is detected by the detector (3) is ascertained, wherein the result of the time measurement is used as a random number.
Patent EP-4064856-A1 (EP)
Inventor: BAHAR MARK
IPC: C12P19/04
Filed: 2020-11-27
Abstract: The present disclosure provides soluble dietary fibers, food and beverage products including them, and methods for making and using them. In one aspect, the disclosure provides soluble dietary fiber having a fiber content of at least 97% as measured by AOAC 2001.03 and a DP1+DP2 content of no more than 3 wt% (e.g., no more than 2 wt%) on a dry solids basis. The soluble dietary fiber can be useful in variety of food and beverage applications including fermented foods and beverages like beer and sake, as well as foods and beverages useful in keto diets.
Patent EP-4087624-A1 (EP)
Inventor: DEANGLIS ASHLEY
IPC: A61L24/04
Filed: 2020-12-17
Abstract: La présente invention concerne des agents de scellement hémostatiques ayant un substrat poreux comprimé, un composant contenant un groupe électrophile qui n'est pas la gélatine ou le collagène, un composant contenant un groupe nucléophile et un agent tampon. La présente invention concerne également un procédé de fabrication et d'utilisation de tels produits de scellement pour sceller et/ou réaliser une hémostase.
Patent EP-3999509-A1 (EP)
Inventor: REDDY JAYACHANDRA P
IPC: A61P35/00
Filed: 2020-07-15
Abstract: L'invention concerne des sels pharmaceutiquement acceptables d'un modulateur de somatostatine, des formes cristallines de sels pharmaceutiquement acceptables du modulateur de somatostatine, des procédés de préparation de ces sels et formes cristallines, des compositions pharmaceutiques et des médicaments comprenant de tels sels et formes cristallines, et des procédés d'utilisation de ces sels et formes cristallines dans le traitement d'affections, de maladies ou de troubles qui pourraient bénéficier de la modulation de l'activité de la somatostatine.
Patent EP-4076490-A1 (EP)
Inventor: XU PING
IPC: C07H21/04
Filed: 2020-12-18
Abstract: The present invention provides inhibitors of fucosylation during protein expression from mammalian cells. The inhibitors are derived from rhamnose and act by inhibition of GDP-mannose 4,6-dehydratase (GMD). The invention further provides methods of making proteins with reduced level of fucosylation, such as antibodies and antibodies made by the methods of the present invention. Such hypofucosylated or nonfucosylated antibodies may find use, for example, in treatment of human disease in which is it therapeutically beneficial to direct antibody dependent cellular cytotoxicity (ADCC) mediated killing of cells expressing the antibody target on their surface, for example in depletion of Tregs in cancer patients using a hypofucosylated or nonfucosylated anti-CTLA-4 antibody.
Patent EP-4000323-A1 (EP)
Inventor: DA SILVA ICARO L J
IPC: H04W52/02
Filed: 2020-07-03
Abstract: L'invention concerne un dispositif sans fil qui exécute un procédé de mise à jour d'une configuration mémorisée. Pendant qu'il est dans un état d'économie d'énergie, le dispositif sans fil surveille un canal de radiomessagerie. Lorsque le dispositif sans fil reçoit un message de radiomessagerie sur le canal de radiomessagerie, il détermine si le canal de radiomessagerie comprend un message relatif à la mise à jour d'une configuration mémorisée du dispositif sans fil. Si le canal de radiomessagerie comprend un message relatif à la mise à jour de la configuration mémorisée du dispositif sans fil, le dispositif sans fil effectue des actions déterminées par ledit message.
Patent EP-3984809-A1 (EP)
Inventor: YANG SEONG YEOL
IPC: B60L53/66
Filed: 2020-07-30
Abstract: In a charging management device, a wireless charging system, a server, and a method for providing wireless charging services according to embodiments of the present disclosure, the server is a server for managing wireless charging of a vehicle on a road and includes at least one processor, at least one memory that stores computer program instructions that, when executed, cause the at least one processor to perform operations, and a communication device configured to communicate with the vehicle and a charge control device. The operations include receiving, from the vehicle, a traveling route and location information of the vehicle, identifying at least one wireless charging station through which the vehicle passes on the traveling route based on the traveling route and the location information, and providing information on at least one identified wireless charging station to the vehicle.
Patent EP-3998652-A1 (EP)
Title: Battery pack incorporating battery module and rigid beam and adopting reverse assembly method
Inventor: CHI HO-JUNE
IPC: H01M2/10
Filed: 2020-08-05
Abstract: Disclosed is a battery pack, which includes a plurality of battery modules and a pack case in which the battery modules are fixedly installed, the battery case includes a pack tray located at a lower portion of the battery modules, and a pack cover coupled with the pack tray to cover the battery modules, and each of the battery modules is fixedly coupled to the pack cover and includes battery cells arranged in one direction, a module case for accommodating the battery cells in an inner space thereof, and a rigid beam disposed between the battery cells inside the module case.
Patent EP-4020894-A1 (EP)
Title: Vehicle onboard network system
Inventor: KUROKAWA YOSHIMASA
IPC: H04L12/28
Filed: 2020-08-06
Abstract: A central control device and a plurality of relay devices constitute a backbone network. Each of the relay device includes: a backbone-side communication port connected to a backbone network; a plurality of device-side communication ports configured to input and output a signal to/from an onboard device; and a first interface conversion device configured to perform interface conversion between the backbone-side communication port and the device-side communication ports. The device-side communication ports include a plurality of general-purpose communication ports to which a common input circuit and/or output circuit is connected. A predetermined first onboard device is directly connected to the general-purpose communication ports, whereas a predetermined second onboard device is connected to the general-purpose communication ports via a predetermined first onboard device.
Patent EP-4030971-A1 (EP)
Inventor: Juchniewicz Richard
IPC: A47D9/02
Filed: 2020-09-21
Abstract: An infant care apparatus includes an infant holder, a drive section, a biometric sensor, and a controller. The drive section is coupled to the infant holder and has a motor configured to generate one or more of an action and a motion of the infant holder. The biometric sensor is configured to observe at least one characteristic of an infant within the infant holder. The controller is configured to employ a neural network or state machine that is communicably coupled to the biometric sensor and the drive section, where the controller registers sensor data from the biometric sensor and effects, through the neural network or the state machine, a change in the one or more of the action and the motion of the infant holder.
Patent EP-4033010-A1 (EP)
Inventor: MISU YOSHITATSU
IPC: C25B3/25
Filed: 2020-09-18
Abstract: This method for controlling an organic hydride generation system 1 includes controlling the potential of an anode electrode 12 and a cathode electrode 16 provided to an electrolysis tank 2 so that the change in potential in the electrode having the higher deterioration rate, among the anode electrode 12 and the cathode electrode 16, is less than the change in potential of the electrode having the lower deterioration rate.
Patent EP-4023068-A1 (EP)
Inventor: TAKAMORI KIYOTO
IPC: A61K31/122
Filed: 2020-09-30
Abstract: It is an object of the present invention to provide a solid drug that is very convenient to transport and store. In order to achieve the object, a drug according to the present invention is a solid drug that includes a radical generating catalyst and a radical generation source.
Patent EP-4040153-A1 (EP)
Inventor: KOSOKU YOSHINORI
IPC: G01N33/53
Filed: 2020-09-02
Abstract: Two different antibodies that specifically bind to tau protein or phosphorylated tau protein are used. One of the two different antibodies is a first antibody immobilized on a support or labeled with a molecule capable of binding to the support, and the other of the two different antibodies is a second antibody labeled without being immobilized on the support. The tau protein includes an N-terminal domain, a C-terminal domain, and an intermediate domain located between the N-terminal and C-terminal domains. Epitopes recognized by the first and second antibodies are each an amino acid sequence contained in the intermediate domain or an amino acid sequence contained in the N-terminal domain. One of the first and second antibodies is first subjected to an antigen-antibody reaction with the blood sample, and the other of the first and second antibodies is subsequently subjected to an antigen-antibody reaction with the blood sample.
Patent EP-4029055-A1 (EP)
Inventor: JOO SUNG CHUL
IPC: H01L29/872
Filed: 2020-08-19
Abstract: A system configured to increase a reliability of electrical connections in a device. The system including a lead configured to electrically connect a pad of at least one support structure to a pad of at least one electrical component. The lead includes an upper portion that includes a lower surface arranged on a lower surface thereof. The lower surface of the upper portion is arranged vertically above a first upper surface of a first pad connection portion; and the lower surface of the upper portion is arranged vertically above a second upper surface of the second pad connection portion. A process configured to increase a reliability of electrical connections in a device is also disclosed.
Patent EP-4041906-A1 (EP)
Inventor: LARMAN HARRY B
IPC: C12Q1/6851
Filed: 2020-10-08
Abstract: L'invention concerne le domaine de l'analyse de l'ARN. Plus particulièrement, la présente invention concerne des compositions et des procédés pour la détection hautement multiplexée d'ARN associé à un pathogène. Dans un mode de réalisation spécifique, un procédé de formation d'un proxy d'acide ribonucléique (ARN) cible dans un échantillon comprend les étapes suivantes : (a) mise en contact d'un échantillon avec une ou plusieurs sondes multipartites s'hybridant à un ARN cible, la ou les sondes multipartites comprenant (i) une sonde de capture de cible, (ii) une sonde accepteur en 3' et (iii) une sonde donneuse phosphorylée en 5'; (b) incubation de l'échantillon de l'étape (a) dans des conditions permettant l'hybridation de la ou des sondes multipartites à l'ARN cible présent dans l'échantillon; (c) immobilisation les sondes de capture cibles sur un support solide; (d) lavage des sondes multi-parties non liées; et (e) ligature des sondes acceptrices et des sondes donneuses pour former un proxy d'ARN cible.
Patent EP-4049090-A1 (EP)
Inventor: ISHIKAWA KEIICHI
IPC: G03G9/087
Filed: 2020-10-13
Abstract: A toner particle includes a binder resin, a colorant, and a wax. The binder resin includes an amorphous polyester resin and a crystalline polyester resin. The amorphous polyester resin includes, as monomer units, a first monomer having a pendant group, terephthalic acid, and ethylene glycol.
Patent EP-4054944-A1 (EP)
Inventor: KRIESEL MATTHEW WAYNE
IPC: B65D75/20
Filed: 2020-11-06
Abstract: Une combinaison de récipient à enroulement flexible unique et réutilisable peut être enroulée de manière sûre ou pliée d'une autre manière sur elle-même dans une configuration généralement de l'avant vers l'arrière, puis déroulée ou dépliée pour une utilisation ultérieure. La combinaison de récipient à enroulement flexible comprend un revêtement thermodurci viscoélastomère disposé sur une base de support flexible. De préférence, le revêtement thermodurci viscoélastomère possède des propriétés adhésives, cohésives et de décollement exceptionnelles. La combinaison de récipient à enroulement flexible peut maintenir un article pouvant être stocké collé dans une position immobilisée jusqu'à ce qu'il soit retiré intentionnellement de celui-ci par un utilisateur. Dans certains modes de réalisation, la combinaison de récipient à enroulement flexible peut présenter des propriétés anti-pathogènes et/ou de nettoyage.
Patent EP-4057840-A1 (EP)
Inventor: SAWYER KENNETH I
IPC: A61K31/05
Filed: 2020-11-13
Abstract: The present disclosure describes a method for treating a disease or condition selected from Parkinson's disease, traumatic brain injury, concussion, chronic traumatic encephalopathy, spinal cord injury, Sjögren's syndrome, Hashimoto's disease, lupus, psoriasis, psoriatic arthritis, rheumatoid arthritis, graft vs. host disease, hypogonadism, male metabolic syndrome, menopausal hormone insufficiency, and ocular surface disease, the method comprising topical administration of a testosterone composition to the forehead.
Patent EP-4058154-A1 (EP)
Inventor: MACKTOOM RIMSHA
IPC: A61K36/9066
Filed: 2020-10-16
Abstract: Antiperspirant/deodorant compositions are described. Said antiperspirant/deodorant compositions comprise, in a cosmetically acceptable medium, (a) at least one cosmetic ingredient obtained from Bamboo, (b) at least one cosmetic ingredient obtained from Maranta Arundinaceae (Arrowroot); and (c) at least one natural starch. These antiperspirant/deodorant compositions are useful in reducing body odor and in wetness absorption. A method for the cosmetic treatment of body odors, in particular axillary odors, which includes applying, to the skin, in particular the axillae, these compositions is also described.
Patent EP-4059519-A1 (EP)
Inventor: SENO MASAHARU
IPC: C12N1/21
Filed: 2020-11-10
Abstract: An object of the present invention is to develop a technique of reducing cancer stem cells. The solution is to provide a human-derived anti-human Cripto-1 antibody containing specific amino acid sequences.
Patent EP-4050863-A1 (EP)
Inventor: SU JIANKANG
IPC: H04L29/12
Filed: 2020-11-27
Abstract: This application provides a domain name query method and a related device. The method includes: An HTTPDNS server receives an HTTP request packet sent by a terminal device, where the HTTP request packet carries a to-be-accessed domain name and scheduling information of the terminal device. The HTTPDNS server constructs a DNS query packet based on the HTTP request packet, and sends the DNS query packet to an authoritative DNS server, where the DNS query packet carries the to-be-accessed domain name and the scheduling information; receives a DNS reply packet sent by the authoritative domain name server, where the DNS reply packet carries an IP address of a to-be-accessed site, and the to-be-accessed site is an edge cache node that is selected by the authoritative domain name server from a plurality of sites of the to-be-accessed domain name and that corresponds to the scheduling information; and constructs an HTTP reply packet based on the DNS reply packet, and sends the HTTP reply packet to the terminal device, where the HTTP reply packet carries the IP address of the to-be-accessed site.
Patent EP-4112158-A1 (EP)
Inventor: FUKUNAGA HAJIME
IPC: B01J13/00
Filed: 2020-10-29
Abstract: The present invention provides a method of efficiently manufacturing an emulsion that is improved in monodispersibility by a membrane emulsification method. The manufacturing method for an emulsion of the present invention includes circulating a mixed liquid containing a water phase and an oil phase in a circulation circuit including one or more tanks, a porous body, liquid-delivering means, and circulation pipes configured to connect the tanks, the porous body, and the liquid-delivering means so that the mixed liquid passes through the porous body a plurality of times, wherein the circulation circuit further includes a gas-separating device, and wherein the gas-separating device is configured to remove air bubbles from the mixed liquid therethrough.
Patent EP-4118521-A1 (EP)
Inventor: WU JIANGANG
IPC: G06F3/06
Filed: 2020-03-10
Abstract: L'invention concerne des procédés, des systèmes et des dispositifs pour gérer des files d'attente d'un sous-système de mémoire. Une première instruction peut être attribuée à une première file d'attente d'une puce mémoire d'un sous-système de mémoire. La première file d'attente peut être associée à un premier niveau de priorité et la puce mémoire peut comprendre une seconde file d'attente associée à un second niveau de priorité différent du premier niveau de priorité. La seconde file d'attente peut comprendre une seconde instruction, la première instruction et la seconde instruction étant chacune associée à une opération respective à effectuer sur le sous-système de mémoire. Dans certains exemples, la première instruction peut être émise avant la seconde instruction sur la base des premier et second niveaux de priorité.
Patent EP-4123020-A1 (EP)
Title: New biological nitrification-inhibiting bacteriophages and use of same
Inventor: ATARES REAL SERGIO
IPC: C12N7/00
Filed: 2020-03-19
Abstract: The invention provides new bacteriophages and variants thereof capable of inhibiting the proliferation and/or growth of nitrifying microorganisms present in the soil, responsible for the nitrification of agricultural soils, in particular capable of inhibiting the proliferation and/or growth of ammonia-oxidising bacteria, such as Nitrosomonas sp, Nitrosomonas aestuarii, Nitrosomonas communis, Nitrosomonas europaea, Nitrosomonas eutropha, Nitrosomonas halophila, Nitrosomonas marina, Nitrosomonas nitrosa, Nitrosomonas oligotropha, Nitrosomonas ureae, Nitrosospira sp, Nitrosospira multiformis, Nitrosospira tenuis.
Patent EP-3964311-A1 (EP)
Inventor: OKUNO SUSUMU
IPC: B23B27/14
Filed: 2020-04-10
Abstract: Provided is a cutting tool including a base material and a coating layer provided on the base material, the coating layer including a titanium carbonitride layer provided on the base material, an intermediate layer provided on the titanium carbonitride layer in contact therewith, and an alumina layer provided on the intermediate layer in contact therewith, the intermediate layer being composed of a compound made of titanium, carbon, oxygen, and nitrogen, the intermediate layer having a thickness of more than 1 µm, when P<sub>C1</sub> atomic % represents an atomic ratio of the carbon in an interface between the intermediate layer and the alumina layer, and P<sub>C2</sub> atomic % represents an atomic ratio of the carbon at a point A away from the interface by 1 µm on a side of the intermediate layer, a ratio P<sub>C1</sub>/P<sub>C2</sub> of the P<sub>C1</sub> to the P<sub>C2</sub> being more than or equal to 1.03.
Patent EP-4155433-A1 (EP)
Inventor: HOSHINO YUKI
IPC: C25B9/00
Filed: 2020-05-18
Abstract: In the present invention, a first supply standard quantity indicating the hydrogen quantity to be supplied to a second production device (40) is determined. It is determined whether the remaining hydrogen quantity in a storage device (20) at the start of a target term is within a standard range. (1) If the remaining hydrogen quantity is within the standard range, (1-a) in a case where the first supply standard quantity is within a range of a consumption lower limit value to a consumption upper limit value regarding hydrogen consumption in the second production device (40), then control is performed such that the first supply standard quantity is set as the hydrogen supply quantity from the storage device (20) to the second production device (40). (2) If the remaining hydrogen quantity is not within the standard range, a second supply standard quantity, which is a standard for the hydrogen supply quantity to the second production device (40) such that the remaining hydrogen quantity in the storage device (20) when the target term ends is within the standard range, is determined, and (2-a) in a case where the second supply standard quantity is within the range of the consumption lower limit value to the consumption upper limit value with respect to hydrogen consumption in the second production device (40), then the second supply standard quantity is set as the hydrogen supply quantity from the storage device (20) to the second production device (40).
Patent EP-4007759-A1 (EP)
Inventor: YANG ZHIXIANG
IPC: A61K31/427
Filed: 2020-08-06
Abstract: Provided are β-lactam compounds of formula (I), their preparation and use as antibiotic agents for the treatment of bacterial infections: Wherein X, W, R  1 , R  2  and R  3  are defined herein.